Skyscape Web Viewer : Evidenced-Based Medicine Guidelines (EBMG) : Main Index

View All
Anticoagulant therapy
Anticoagulant therapy
Anticoagulant therapy
Anticoagulant
Anticoagulation, oral
Anticoagulation therapy Increased Pulmonary Blood Pressure: Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Interventions for Haemolytic Uraemic Syndrome (Hus) and Thrombotic Thrombocytopenic Purpura (TTP) Low-Intensity Warfarin for Long-Term Prevention of Venous Thromboembolism Selecting Anticoagulant Therapy in Atrial Fibrillation Subconjunctival Haemorrhage (Suggillation) Treatment of Distal Deep Vein Thrombosis Warfarin or Antiplatelet Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Anticoagulation treatment Antiplatelet Therapy for Patients with Non-Valvular Atrial Fibrillation Indications for and Implementation of Anticoagulant Therapy in Atrial Fibrillation Treatment of Distal Deep Vein Thrombosis
Anticoagulation
Anticoagulation
Anticoagulation
Anticonvulsants
Anticonvulsants
Anticonvulsants
Anticonvulsant
Anti-depressant medication
Antidepressants
Antidepressants
Antidepressants
Antidepressant
Antidepressant
Antidepressive Agents, Tricyclic
Antidepressive Agents, Tricyclic
Antidepressive Agents, Tricyclic
Antidepressive Agents
Antidepressive Agents
Antidepressive Agents
Antidiabetic Agents Dipeptidyl Peptidase-4 (Dpp-4) Inhibitors for Type 2 Diabetes Mellitus Meglitinide Analogues (Glinides) for Type 2 Diabetes Mellitus Pioglitazone for Type 2 Diabetes Mellitus Sglt-2 Inhibitors in Type 2 Diabetes Sulphonylurea for Type 2 Diabetes
Antidiabetic drug, oral Comprehensive Treatment and Follow-Up of Type 2 Diabetes Insulin Therapy in Type 2 Diabetes
Antidiabetic drug
Anti-diabetic pharmacological therapy